N-methyl-D-aspartate (NMDA) receptor dysfunction is involved in the pathogenesis of schizophrenia. We determined the nucleotide sequence of the 5′-upstream region of the human NMDA receptor 2B (NR2B) subunit gene and identified a novel T-200G variant located in one of the Sp1 binding sites. To investigate the effect of this variant on the transcriptional activity of the hNR2B gene, we performed gene reporter assays using PC12 pheochromocytoma cells transiently transfected with luciferase reporter plasmids. In the absence of nerve growth factor (NGF), luciferase activities did not significantly differ between the two alleles and the control plasmid. However, luciferase reporter activity of the T allele was significantly up-regulated compared to that of the G allele in the presence of NGF (P = 0.0013), indicating that this polymorphic site is a critical region for NR2B gene regulation through NGF-induced Sp1-binding. A case control study showed that the frequency of the G allele (P = 0.0164) was significantly higher in 100 schizophrenics than in 100 controls. These findings suggest that the T-200G variant causes dysfunction of NMDA receptors consisting of the NR2B subunit and may be involved in the development of schizophrenia. Replication studies of independent samples and family-based association studies are necessary to further evaluate the significance of our findings.
Introduction
Schizophrenia is a relatively common, chronic and debilitating psychiatric disorder. Studies involving twins, families, and adopted children suggest that genetic factors are of major etiologic importance. 1, 2 The mode of transmission is complex, and perhaps involves multiple responsive genes and/or genetic heterogeneity. 3 Several studies have suggested that suppression of glutamatergic neurons in the frontal cortex is involved in the pathogenesis of schizophrenia; this is known as the glutamate dysfunction hypothesis. 4 Administration of N-methyl-D-aspartate (NMDA) receptor antagonists, namely phencyclidine, ketamine and MK-801, to healthy individuals mimicked positive and negative symptoms of schizophrenia, such as cognitive dysfunction. 5 These drugs also profoundly exacerbate both positive and negative symptoms in schizophrenic patients. 6 On the other hand, NMDA receptor agonists, namely glycine and D-cycloserine, improve schizophrenic symptoms and are useful therapy for schizophrenia. 7, 8 NMDA receptors comprise a small family of ionotropic glutamate receptors that play a role in brain development, excitatory neurotransmission, synaptic plasticity, and memory formation. 9 Native NMDA receptors are thought to be composed of a common NMDAR1 subunit and one NMDAR2 subunit. The expression of different combinations of these subunits in vivo indicates that the functional properties of NMDA receptors are regulated in part through the differential gene expression of individual subunits 10, 11 Human NMDAR2B (hNR2B) cDNA has been cloned from a fetal brain cDNA library and mapped to chromosome 12p12.
12,13 hNR2B mRNA is primarily expressed in the fronto-temporal cortex and hippocampus in the adult brain.
14 Long-term synaptic depression of hippocampal neurons is abolished, and formation of synaptic plasticity involved in learning and memory is impaired in mice with a disrupted ε2 subunit (ie, the mouse counterpart of hNR2B). 15 In contrast, learning and memory in various behavioral tasks are enhanced in mice overexpressing the ε2 subunit gene, indicating that NR2B is critical for synaptic plasticity and memory formation. 16 Nishiguchi et al recently identified a C2664T variant in the carboxyl-terminal intracellular domain of the hNR2B gene, but this was not significantly associated with schizophrenia. 17 However, Ohtsuki et al reported eight variants encoding exons in the 3′-untranslated region of the hNR2B gene, some of which were significantly associated with schizophrenia. 18 In the present study, we sequenced 5′-upstream nucleotides of the hNR2B gene and identified a novel T-200G variant that was significantly associated with schizophrenia. We suggest that this variant is involved in glutamate dysfunction leading to the development of schizophrenia.
Materials and methods

Subjects
We recruited 100 unrelated, ethnic Japanese schizophrenics (55 men and 45 women; mean age of 44.9 ± 12.8 (SD) years) from patients at four hospitals in Kagawa and Tokushima prefectures in Japan. Schizophrenia was diagnosed according to the International Criteria of Disease, tenth edition (ICD-10). 19 The controls comprised 100 healthy individuals without a psychiatric or family history of mental illness (42 men and 58 women; mean age of 40.2 ± 10.2 (SD) years). These unrelated ethnic Japanese were either hospital staff or medical students who came from the same prefectures as the patients. All participants gave written informed consent after the study protocol had been fully explained. This study was approved by the Ethics Committee of Kagawa Medical University.
Cloning of the 5′-upstream region of the hNR2B gene PCR primers were designed downstream of the translation start codon ATG of the hNR2B cDNA 12 then amplified by 5′-rapid amplification of cDNA ends using a Marathon cDNA Human Brain Kit (Clontech, USA). The transcription initiation site was then determined using the Cap site hunting method 20 with a Cap Site cDNA Human Brain Kit (NIPPON GENE, Japan). The upstream region located about −1.4 kbp from the transcription initiation site was sequenced, and the intronexon organization from the 5′-untranslated exon to exon 4 was analyzed using a Human Genome Walker Kit (Clontech).
Detection of gene variants in the 5′-upstream region of the hNR2B gene
Genomic DNAs were isolated from lymphocytes taken from schizophrenics and controls using a QIASPIN Genomic DNA Isolation Kit (QIAGEN, USA). We initially screened for variants in the 5′-upstream region of the hNR2B gene using polymerase chain reactionsingle strand conformation polymorphism (PCR-SSCP) analysis. Pairs of PCR primers were designed to amplify 250-400 bp fragments of approximately 2.0 kbp of hNR2B DNA including the 5′-flanking region, two untranslated exons, and exons 3 and 4. Variants were screened by PCR-SSCP using genomic DNAs from 40 randomly selected schizophrenics. After denaturation at 94°C, the PCR products were resolved on 10-20% gradient gels (acrylamide: N,N′-methylene bisacrylamide, 99:1) at 4°C at a constant current of 300 W for 3 h. Thereafter, the gels were stained using a Silver Stain Plus Kit (Bio-Rad, USA). PCR-amplified fragments with unusual SSCP profiles were reamplified, cloned into TA plasmids (Invitrogen, USA) and sequenced at least five times using a DNA sequencer, Model ABI 377 (Applied Biosystems, USA).
Analysis of the T-200G variant
Analysis by PCR-SSCP detected a T-200G variant in the 5′-upstream region of the hNR2B gene. This variant was genotyped by PCR-restriction fragment length polymorphism (PCR-RFLP) using a mismatched forward primer to produce a HapII recognition site. The sequences of the primer pair were as follows: forward, 5′-GGAGTCAGGGTGTGCGAGGTACCG-3′; reverse, 5′-GGAGGGGAGCGTCAGAAAAATGGGTAT-3′ (underlined position indicates a mismatched site). Fragments were PCR-amplified according to the following parameters: 35 cycles of denaturation at 94°C for 20 s, annealing at 60°C for 20 s and extension at 72°C for 20 s, with a final extension at 72°C for 15 min. The predicted 159-bp products were digested with HapII, then resolved by PAGE on a 10-20% gradient gel. The sizes of the restricted fragments were 122 and 37 bp for the T allele, and 101, 37 and 21 bp for the G allele.
Dual-luciferase gene reporter assay
The 264-bp fragments (from −221 to +43) including T-200G polymorphic sites were PCR-amplified using the following primers: forward, 5′-GGTACCGTCAGGG TGTGCGAGGTA-3′ (includes a KpnI site); and reverse, 5′-AAGCTTGAGCCCAGATTCCAGTTG-3′ (includes a HindIII site). The genomic DNAs with identified genotypes were used as templates. PCR products of both genotypes were cloned into the pGL3-Basic plasmid (Promega, USA). PC12 pheochromocytoma cells were cultured in DMEM supplemented with 5% FCS and 5% HS, as described. 21 The luciferase reporter plasmids, constructed with both alleles, were transiently transfected into the cells using the TransFast lipofection reagent (Promega). The Renilla luciferase expression plasmid, pRL-TK, was co-transfected as an internal standard. After transfection, the cells were incubated with nerve growth factor (NGF) (2.5S; Promega) at a final concentration of 100 ng ml −1 for 20 h, as described by Bai et al. 22 PC12 cells were harvested 48 h later when luciferase activity was maximal (data not shown). At this time, luciferase reporter activity was measured using a TD-20/20 luminometer and a Dual-Luciferase Assay Kit (Promega). All experiments were repeated at least three times.
Statistical analyses
Relative luciferase activity was expressed as means ± SEM. Group differences were compared using the 2 and Bonferroni/Dunn tests. Group differences in the case-control study were evaluated by the 2 test. Probability values of P Ͻ 0.05 were considered significant. Calculations were performed using StatView version 4.5 (Abacus Concepts, USA).
The nucleotide sequence reported in this paper has been submitted to the GenBankTM/EMBL Data Bank, accession number AB064526.
Results
Nucleotide sequence and structure of the human NR2B gene 5′-upstream region Untranslated exons 1 (360 bp) and 2 (353 bp) were located 5'-upstream of the hNR2B gene (Figure 1a) . The translation initiation codon ATG started at the 19th nucleotide in exon 3 (Figure 1b) . Two 5′-untranslated exons have also been identified in the mouse NR2B/ε2 gene. 23 The transcription initiation site determined using the Cap site hunting method 20 was assigned to position 1 of the nucleotide sequence. A (GT) dinucleotide repeat sequence was located at nucleotide position −176 to −201, which is similar to the location of the (GT) 20 dinucleotide repeat site in the promoter region of the mouse NR2B/ε2 gene. The TFSEARCH program revealed several putative transcriptional factor-binding sites within 1.4 kbp upstream of the transcription initiation site. 24 No putative TATA-or CAAT-boxes were found. However, four Sp1 binding sites (−10 to −19, −116 to −123, −200 to −209 and −318 to −332), a GATA-2 site (−253 to −262), two CREB binding sites (−387 to −394 and −731 to −742) and a GATA-1 binding site (−895 to −904) were identified within ෂ1 kb upstream of the transcription initiation site. This configuration is similar to the structure of the 5′-flanking region of the mouse NR2B/ε2 gene.
23,25
Detection and characterization of a variant PCR-SSCP analysis revealed a T-to-G variant at nucleotide position −200, which is part of the (GT) dinucleotide repeat (GT) 7 (CT)(GT) 6 (Figure 2a,b) . This substitution shortened (GT) the dinucleotide repeat (GT) 6 (CT)(GT) 6 , which was located in the putative Sp1 binding site. PCR-RFLP analysis of samples from all participants revealed three genotypes: one homozygous for the T allele, one heterozygous for the T and G alleles and one homozygous for the G allele (Figure 3 ). The T allele was the wild type, because it appeared more frequently than the G allele in the controls (Table  1) . A comparison between schizophrenics and controls showed that the frequency of the G allele was significantly higher in schizophrenics ( 2 = 5.762, df = 1, P = 0.0164, odds ratio = 1.62, 95% confidence interval 1.09-2.40). In addition, the frequency of homozygotes for the G allele was significantly higher in schizophrenics than in controls ( 2 = 7.424, df = 2, P = 0.0244). We found no significant association between the T-200G variant and age of onset, gender, family history, subtype of schizophrenia according to ICD-10 criteria, or clinical incidence of neurolepticinduced side effects.
Transcriptional effects of T-200G variant
To investigate the effect of the T-200G variant on the transcriptional activity of the hNR2B gene, we constructed and transiently transfected luciferase reporter Molecular Psychiatry plasmids, including polymorphic sites, into PC12 pheochromocytoma cells (Figure 4 ). In the absence of NGF, luciferase activity between the two alleles and the control plasmid did not differ significantly. In the presence of NGF, luciferase activity of the plasmid containing the T allele increased 30-fold. In contrast, NGF had essentially no effect on the luciferase activity of the plasmid containing the G allele (P = 0.0013, T allele vs G allele, Bonferroni/Dunn test).
Discussion
We sequenced the 5′-upstream region of the hNR2B gene and found a novel variant that was significantly associated with schizophrenia. Gene reporter assays revealed that this variant dramatically affected the NGF-induced transcriptional activity of the hNR2B gene.
Although the promoter region of the hNR2B gene lacked TATA-and CAAT boxes, it contained several transcription factor binding sites. TATA-boxes are common cis-acting elements that direct the accurate transcription initiation of many genes, but some TATA-less promoters can also direct transcription initiation via GC-rich sequences that bind Sp1. 26, 27 Sp1-binding to GC-rich sequences is important in the regulation of mouse NR2B/ε2 gene transcription. 23, 25 Sp1 is selectively up-regulated in specific developing cells, and it plays a regulatory role during development and differentiation by binding to promoter regions.
28
Sp1 also plays a critical role in the differentiation of oligodendrocytes in the human brain. 29 Therefore, Sp1 may be an important transcription factor required in the regulation of NR2B gene expression in developing neuronal cells of the brain.
NGF is critical for neural differentiation in the peripheral and central nervous systems, 30 where it promotes the growth of neurons through activation of its receptor and the subsequent initiation of intracellular signaling cascades that ultimately influence gene expression. 31 In the presence of NGF, PC12 cells display a sympathetic neuronal-like phenotype characterized by the cessation of proliferation and the promotion of neurite outgrowth; thus, they are widely used as a model in studies involving neural function and development. 32, 33 We found that transcriptional activity of the hNR2B gene considerably increased after exposure to NGF, indicating that NGF-stimulated PC12 cells accurately reproduce transcription of the hNR2B gene within neurons in vitro. NGF also up-regulates transcriptional activity of the NR1 gene in time-and dose-dependent manners by enhancing Sp1-binding to its promoter region. 22 These findings indicate that NGF plays an important role in the expression of NMDA receptors consisting of the NR1 and NR2B subunits.
Gene reporter assays showed that NGF significantly increases the transcriptional activity of the T allele. In contrast, NGF affects G allele transcription to a lesser extent. The T-to-G substitution site is located in one of the putative Sp1 binding sites. Therefore, this single base substitution may decrease the transcriptional activity of the hNR2B gene by suppressing NGFinduced Sp1-binding to the gene promoter region, which in turn may lead to dysfunction of NMDA receptors consisting of NR2B subunits. The case-control study showed that the G allele occurred significantly more frequently in the schizophrenic population than in the control population. These results, together with the results of the gene reporter assays, suggest that the T-200G variant may be involved in the development of schizophrenia. However, because the G allele occurs quite frequently in the population, its odds ratio would be small (1.62, 95% confidence interval 1.09-2.40). Our results should be evaluated against the background that the finding was obtained in a sample of moderate size. In addition, it is known that case-control studies can also be prone to spurious results due to stratification effects. Therefore, replication studies are clearly needed to confirm the role of the T-200G variant in the development of schizophrenia. Given the small odds Molecular Psychiatry Figure 4 Relative luciferase activity of the T allele and G allele. There are no significant differences in the relative luciferase promoter activity values among the control vector, T allele and G allele without NGF-treatment (n = 3). Fortyeight hours after NGF treatment, there are significant differences in relative luciferase activity between the T allele and the control vector and between the T allele and the G allele (n = 3), *P = 0.001, Bonferroni/Dunn test, T-allele vs control, **P = 0.0013, Bonferroni/Dunn test, T allele vs G allele. ratio, the replication samples (cases-controls or parent-offspring trios) need to have a large size to achieve the statistical power necessary to detect a genetic effect of that magnitude.
A positive association between schizophrenia and variants in coding exons and variants in the 3′-untranslated region of the NR2B gene suggests that the NR2B gene locus, when in linkage disequilibrium with these regions, confers susceptibility to schizophrenia. 18 Whether these variants and the T-200G variant are in linkage disequilibrium remains unknown. Therefore, further study in the same sample is required to determine the association among these variants in the NR2B gene.
In conclusion, we suggest that the T-200G variant causes dysfunction of NMDA receptors consisting of NR2B subunits and that this substitution is involved in the development of schizophrenia. Replication studies in independent samples and family-based association studies are necessary to further evaluate our findings.
